Literature DB >> 10813483

Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission.

C S Sokhna1, C Rogier, A Dieye, J F Trape.   

Abstract

To investigate host factors affecting the delay of reappearance of malaria parasites after radical treatment, a study was undertaken in Dielmo, Senegal, an area of intense perennial malaria transmission. A 7-day course of quinine was administered to 173 asymptomatic persons from 1 to 85 years of age and reappearance of malaria parasites in the peripheral blood was monitored weekly for 14 weeks. Additional thick blood films were made in case of fever as part of a daily clinical surveillance. The median times before reappearance of Plasmodium falciparum were 22, 39, and 53 days among persons 1-6, 7-14, and > or = 15 years of age, respectively (P < 0.0001). Multivariate analysis indicated that the daily rate of reappearance of P. falciparum was 2.2 (95% confidence interval [CI] = 1.2-4.5) times lower in sickle cell trait carriers than in AA individuals, and 1.5 (95% CI = 1.1-2.1) times lower in bed nets users than in non-users. The risk ratio for the daily risk of reappearance was significantly related to the level of parasitemia before treatment. No influence of glucose-6-phosphate dehydrogenase deficiency, HLA-B53, and DR13 were observed. Findings show that monitoring during a few weeks the reappearance of malaria parasites after treatment among a small cohort of individuals naturally exposed to malaria is relevant for investigating host resistance factors. This suggest that small, low-cost, field trials may be very informative on the potential of new malaria vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813483     DOI: 10.4269/ajtmh.2000.62.266

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Sickle cell trait protects against Plasmodium falciparum infection.

Authors:  Mounkaila A Billo; Eric S Johnson; Seydou O Doumbia; Belco Poudiougou; Issaka Sagara; Sory I Diawara; Mahamadou Diakité; Mouctar Diallo; Ogobara K Doumbo; Anatole Tounkara; Janet Rice; Mark A James; Donald J Krogstad
Journal:  Am J Epidemiol       Date:  2012-10-01       Impact factor: 4.897

2.  Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population.

Authors:  Mykola Pinkevych; Janka Petravic; Kiprotich Chelimo; John Vulule; James W Kazura; Ann M Moormann; Miles P Davenport
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

3.  Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections.

Authors:  Peter Liehl; Patrícia Meireles; Inês S Albuquerque; Mykola Pinkevych; Fernanda Baptista; Maria M Mota; Miles P Davenport; Miguel Prudêncio
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

Review 4.  How malaria has affected the human genome and what human genetics can teach us about malaria.

Authors:  Dominic P Kwiatkowski
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

5.  An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection.

Authors:  Tuan M Tran; Shanping Li; Safiatou Doumbo; Didier Doumtabe; Chiung-Yu Huang; Seydou Dia; Aboudramane Bathily; Jules Sangala; Younoussou Kone; Abdrahamane Traore; Moussa Niangaly; Charles Dara; Kassoum Kayentao; Aissata Ongoiba; Ogobara K Doumbo; Boubacar Traore; Peter D Crompton
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

6.  Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.

Authors:  Mykola Pinkevych; Janka Petravic; Kiprotich Chelimo; John Vulule; James W Kazura; Ann M Moormann; Miles P Davenport
Journal:  J Infect Dis       Date:  2013-11-21       Impact factor: 5.226

7.  Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria.

Authors:  Peter D Crompton; Boubacar Traore; Kassoum Kayentao; Safiatou Doumbo; Aissata Ongoiba; Seidina A S Diakite; Michael A Krause; Didier Doumtabe; Younoussou Kone; Greta Weiss; Chiung-Yu Huang; Seydou Doumbia; Aldiouma Guindo; Rick M Fairhurst; Louis H Miller; Susan K Pierce; Ogobara K Doumbo
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

8.  Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.

Authors:  Adama Tall; Cheikh Sokhna; Ronald Perraut; Didier Fontenille; Laurence Marrama; Alioune B Ly; Fatoumata D Sarr; Aïssatou Toure; Jean-François Trape; André Spiegel; Christophe Rogier; Pierre Druilhe
Journal:  Malar J       Date:  2009-07-15       Impact factor: 2.979

9.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

10.  High number of previous Plasmodium falciparum clinical episodes increases risk of future episodes in a sub-group of individuals.

Authors:  Cheikh Loucoubar; Laura Grange; Richard Paul; Augustin Huret; Adama Tall; Olivier Telle; Christian Roussilhon; Joseph Faye; Fatoumata Diene-Sarr; Jean-François Trape; Odile Mercereau-Puijalon; Anavaj Sakuntabhai; Jean-François Bureau
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.